Orchev Pharma

Rajkot, India Founded: 1989 • Age: 37 yrs
Manufactures high-quality pharmaceutical APIs and intermediates for global exports.

About Orchev Pharma

Orchev Pharma is a Healthcare company based in Rajkot (India) founded in 1989. It manufactures high-quality pharmaceutical APIs and intermediates for global exports. It operates on a B2B model. The company has 28 employees. Its Indian entity Orchev Pharma Pvt Ltd reported revenue of β‚Ή59.72 Cr. Orchev Pharma offers products and services including Famotidine, Ranitidine, Telmisartan, Levetiracetam, and Allopurinol. Its focus areas include Pharmaceuticals, API Manufacturing, Drug Intermediates and Active Ingredients. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Orchev Pharma Pvt. Ltd., established in 1989 in Gujarat, India, specializes in manufacturing active pharmaceutical ingredients such as Ranitidine, Famotidine, Telmisartan, and Levetiracetam. The company operates under strict standards like USFDA and WHO-GMP, focusing on quality assurance, research, and exports to international markets. It provides services including contract manufacturing and trial supplies, serving global clients through B2B relationships.

  • Headquarters Rajkot, India
  • Employees 28
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website orchev.com
  • Social LinkedIn
  • Legal Name Orchev Pharma Pvt Ltd
  • Date of Incorporation 28 Jun, 1989
  • Jurisdiction Rajkot, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹59.72 Cr

    FY 2026 · +37% YoY

  • Net Profit
    ₹40.7 Lakh

    FY 2026 · 1% margin

  • EBITDA
    ₹1.69 Cr

    FY 2026 · 3% margin

  • Employee Count
    28

Products & Services of Orchev Pharma

Orchev Pharma offers a comprehensive portfolio of products and services, including Famotidine, Ranitidine, Telmisartan, Levetiracetam, and Allopurinol.

Famotidine
API

Active ingredient used for treating acid-related disorders.

Ranitidine
API

Active ingredient for gastric acid reduction therapy.

Telmisartan
API

Active ingredient for managing high blood pressure.

Levetiracetam
API

Active ingredient for treating epilepsy seizures.

Allopurinol
API

Active ingredient for gout and kidney stone prevention.

Board of directors of Orchev Pharma Pvt Ltd (Orchev Pharma)

Orchev Pharma Pvt Ltd is the primary company behind Orchev Pharma. The board of Orchev Pharma Pvt Ltd currently have 4 directors; the longest-serving is Vasantlal Odhavjibhai Bhalodia, appointed in 1989. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Vasantlal Odhavjibhai Bhalodia
DIN 00544069
Managing Director28 Jun 198937 yrs 4 moOrchev Pharma Pvt Ltd
Kanchanben Vasantlal Bhalodia
DIN 00544082
Director03 Oct 199234 yrs 1 moOrchev Pharma Pvt Ltd
Viren Vasant Patel
DIN 00544034
Director01 Jun 200620 yrs 5 moOrchev Pharma Pvt Ltd
Chirag Vasantbhai Patel
DIN 00544051
Director01 Aug 200620 yrs 3 moOrchev Pharma Pvt Ltd

Financials of Orchev Pharma

Figures of Orchev Pharma Pvt Ltd, the primary company behind Orchev Pharma, for FY 2026. Revenue was ₹59.72 Cr (+37% year on year). Net profit was ₹40.7 Lakh (1% margin). EBITDA was ₹1.69 Cr (3% margin). Revenue has grown at a compounded annual rate of +21% over three years and +29% over five years.

  • ₹59.72 CrRevenue · FY 2026 · +37% YoY
  • ₹40.7 LakhNet profit · 1% margin
  • ₹1.69 CrEBITDA · 3% margin
  • ₹99.9 LakhPaid-up capital
  • 43Employees (provident fund records)
  • +21%Revenue CAGR, 3 years
  • +29%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Orchev Pharma Pvt Ltd are on its company page.

Premium access

Detailed financial statements for Orchev Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Orchev Pharma

Orchev Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Orchev Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Orchev Pharma

Orchev Pharma was founded in 1989.

Orchev Pharma is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.

Orchev Pharma has 28 employees.

The primary company behind Orchev Pharma, Orchev Pharma Pvt Ltd, reported revenue of β‚Ή59.72 Cr for FY 2026, up 37% year on year.

Orchev Pharma Pvt. Ltd., established in 1989 in Gujarat, India, specializes in manufacturing active pharmaceutical ingredients such as Ranitidine, Famotidine, Telmisartan, and Levetiracetam. The company operates under strict standards like USFDA and WHO-GMP, focusing on quality assurance, research, and exports to international markets. It provides services including contract manufacturing and trial supplies, serving global clients through B2B relationships.

Orchev Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.

Orchev Pharma offers Famotidine, Ranitidine, Telmisartan, Levetiracetam, and Allopurinol.

Orchev Pharma operates through Orchev Pharma Pvt Ltd.

The legal entities of Orchev Pharma currently have 4 directors, including Chirag Vasantbhai Patel, Vasantlal Odhavjibhai Bhalodia, Viren Vasant Patel and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available